Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 147

1.

A synthetic human cytomegalovirus pp65-IE1 fusion antigen efficiently induces and expands virus specific T cells.

Link EK, Brandmüller C, Suezer Y, Ameres S, Volz A, Moosmann A, Sutter G, Lehmann MH.

Vaccine. 2017 Sep 12;35(38):5131-5139. doi: 10.1016/j.vaccine.2017.08.019. Epub 2017 Aug 14.

PMID:
28818566
2.

Ectromelia virus accumulates less double-stranded RNA compared to vaccinia virus in BS-C-1 cells.

Frey TR, Lehmann MH, Ryan CM, Pizzorno MC, Sutter G, Hersperger AR.

Virology. 2017 Sep;509:98-111. doi: 10.1016/j.virol.2017.06.010.

3.

CCL2 expression is mediated by type I IFN receptor and recruits NK and T cells to the lung during MVA infection.

Lehmann MH, Torres-Domínguez LE, Price PJ, Brandmüller C, Kirschning CJ, Sutter G.

J Leukoc Biol. 2016 Jun;99(6):1057-64. doi: 10.1189/jlb.4MA0815-376RR. Epub 2016 Mar 18. Review.

PMID:
26992431
4.

Modified Vaccinia virus Ankara but not vaccinia virus induces chemokine expression in cells of the monocyte/macrophage lineage.

Lehmann MH, Price PJ, Brandmüller C, Sutter G.

Virol J. 2015 Feb 12;12:21. doi: 10.1186/s12985-015-0252-1.

5.

Complement component C5 recruits neutrophils in the absence of C3 during respiratory infection with modified vaccinia virus Ankara.

Price PJ, Bánki Z, Scheideler A, Stoiber H, Verschoor A, Sutter G, Lehmann MH.

J Immunol. 2015 Feb 1;194(3):1164-8. doi: 10.4049/jimmunol.1301410. Epub 2014 Dec 29.

6.

Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial.

Kreijtz JH, Goeijenbier M, Moesker FM, van den Dries L, Goeijenbier S, De Gruyter HL, Lehmann MH, Mutsert Gd, van de Vijver DA, Volz A, Fouchier RA, van Gorp EC, Rimmelzwaan GF, Sutter G, Osterhaus AD.

Lancet Infect Dis. 2014 Dec;14(12):1196-207. doi: 10.1016/S1473-3099(14)70963-6. Epub 2014 Oct 30.

PMID:
25455987
7.

Chemokine (C-C Motif) receptor 1 is required for efficient recruitment of neutrophils during respiratory infection with modified vaccinia virus Ankara.

Price PJ, Luckow B, Torres-Domínguez LE, Brandmüller C, Zorn J, Kirschning CJ, Sutter G, Lehmann MH.

J Virol. 2014 Sep;88(18):10840-50. doi: 10.1128/JVI.01524-14. Epub 2014 Jul 9.

8.

Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial.

Choi SW, Braun T, Chang L, Ferrara JL, Pawarode A, Magenau JM, Hou G, Beumer JH, Levine JE, Goldstein S, Couriel DR, Stockerl-Goldstein K, Krijanovski OI, Kitko C, Yanik GA, Lehmann MH, Tawara I, Sun Y, Paczesny S, Mapara MY, Dinarello CA, DiPersio JF, Reddy P.

Lancet Oncol. 2014 Jan;15(1):87-95. doi: 10.1016/S1470-2045(13)70512-6. Epub 2013 Nov 30.

9.

Monocyte chemoattractant protein 1-mediated migration of mesenchymal stem cells is a source of intimal hyperplasia.

Grudzinska MK, Kurzejamska E, Hagemann N, Bojakowski K, Soin J, Lehmann MH, Reinecke H, Murry CE, Soderberg-Naucler C, Religa P.

Arterioscler Thromb Vasc Biol. 2013 Jun;33(6):1271-9. doi: 10.1161/ATVBAHA.112.300773. Epub 2013 Apr 18. Erratum in: Arterioscler Thromb Vasc Biol. 2013 Jun;33(6):e122.

PMID:
23599443
10.

Modified Vaccinia virus Ankara: innate immune activation and induction of cellular signalling.

Price PJ, Torres-Domínguez LE, Brandmüller C, Sutter G, Lehmann MH.

Vaccine. 2013 Sep 6;31(39):4231-4. doi: 10.1016/j.vaccine.2013.03.017. Epub 2013 Mar 21. Review.

PMID:
23523404
11.

Prolonged QT interval diagnosis suppression by a widely used computerized ECG analysis system.

Garg A, Lehmann MH.

Circ Arrhythm Electrophysiol. 2013 Feb;6(1):76-83. doi: 10.1161/CIRCEP.112.976803. Epub 2012 Dec 29.

PMID:
23275261
12.

Genetic testing for long QT syndrome and the category of cardiac ion channelopathies.

Modell SM, Bradley DJ, Lehmann MH.

PLoS Curr. 2012 May 3:e4f9995f69e6c7. doi: 10.1371/4f9995f69e6c7.

13.

Easy and efficient protocols for working with recombinant vaccinia virus MVA.

Kremer M, Volz A, Kreijtz JH, Fux R, Lehmann MH, Sutter G.

Methods Mol Biol. 2012;890:59-92. doi: 10.1007/978-1-61779-876-4_4.

PMID:
22688761
14.

Proposed bedside maneuver to facilitate accurate anatomic orientation for correct positioning of ECG precordial leads V1 and V2: a pilot study.

Lehmann MH, Katona AM.

J Emerg Med. 2012 Oct;43(4):584-92. doi: 10.1016/j.jemermed.2012.01.022. Epub 2012 Apr 14.

PMID:
22504082
15.

Critical role of perforin-dependent CD8+ T cell immunity for rapid protective vaccination in a murine model for human smallpox.

Kremer M, Suezer Y, Volz A, Frenz T, Majzoub M, Hanschmann KM, Lehmann MH, Kalinke U, Sutter G.

PLoS Pathog. 2012;8(3):e1002557. doi: 10.1371/journal.ppat.1002557. Epub 2012 Mar 1.

16.

Importance of recognizing pseudo-septal infarction due to electrocardiographic lead misplacement.

Ilg KJ, Lehmann MH.

Am J Med. 2012 Jan;125(1):23-7. doi: 10.1016/j.amjmed.2011.04.023. Epub 2011 Aug 17.

PMID:
21851916
17.

ICD implantation and evidence-based patient selection.

Lehmann MH.

JAMA. 2011 Apr 20;305(15):1539; author reply 1539-40. doi: 10.1001/jama.2011.459. No abstract available.

PMID:
21505130
18.

HIV-1 Nef increases astrocyte sensitivity towards exogenous hydrogen peroxide.

Masanetz S, Lehmann MH.

Virol J. 2011 Jan 22;8:35. doi: 10.1186/1743-422X-8-35.

19.

Brugada syndrome: diagnostic pitfalls.

Lehmann MH, Brugada R.

J Emerg Med. 2009 Jul;37(1):79-81; author reply 81-2. doi: 10.1016/j.jemermed.2008.09.038. Epub 2009 Mar 25. No abstract available.

PMID:
19321285
20.

Modified vaccinia virus ankara triggers chemotaxis of monocytes and early respiratory immigration of leukocytes by induction of CCL2 expression.

Lehmann MH, Kastenmuller W, Kandemir JD, Brandt F, Suezer Y, Sutter G.

J Virol. 2009 Mar;83(6):2540-52. doi: 10.1128/JVI.01884-08. Epub 2009 Jan 7.

21.

Guanylate binding protein-1 inhibits spreading and migration of endothelial cells through induction of integrin alpha4 expression.

Weinländer K, Naschberger E, Lehmann MH, Tripal P, Paster W, Stockinger H, Hohenadl C, Stürzl M.

FASEB J. 2008 Dec;22(12):4168-78. doi: 10.1096/fj.08-107524. Epub 2008 Aug 12.

PMID:
18697840
22.

Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study.

Buxton AE, Lee KL, Hafley GE, Pires LA, Fisher JD, Gold MR, Josephson ME, Lehmann MH, Prystowsky EN; MUSTT Investigators.

J Am Coll Cardiol. 2007 Sep 18;50(12):1150-7. Epub 2007 Sep 4.

23.

Designation and distribution of events in the Multicenter UnSustained Tachycardia Trial (MUSTT).

Fisher JD, Buxton AE, Lee KL, Packer DL, Echt DS, Denes P, Lehmann MH, DiMarco JP, Roy D, Hafley GE; MUSTT Events Committee.

Am J Cardiol. 2007 Jul 1;100(1):76-83. Epub 2007 May 11.

24.

HIV-1 Nef upregulates CCL2/MCP-1 expression in astrocytes in a myristoylation- and calmodulin-dependent manner.

Lehmann MH, Masanetz S, Kramer S, Erfle V.

J Cell Sci. 2006 Nov 1;119(Pt 21):4520-30. Epub 2006 Oct 17.

25.

Prolonged QTc interval and sudden cardiac death in older adults.

Lehmann MH.

J Am Coll Cardiol. 2006 Oct 3;48(7):1473-4; author reply 1474. Epub 2006 Sep 12. No abstract available.

26.

Extracellular HIV-1 Nef increases migration of monocytes.

Lehmann MH, Walter S, Ylisastigui L, Striebel F, Ovod V, Geyer M, Gluckman JC, Erfle V.

Exp Cell Res. 2006 Nov 1;312(18):3659-68. Epub 2006 Aug 16.

PMID:
16978607
27.

Chemotactic activity of serum obtained from patients with idiopathic dilated cardiomyopathy.

Sigusch HH, Lehmann MH, Reinhardt D, Henke A, Zell R, Leipner C, Figulla HR.

Pharmazie. 2006 Aug;61(8):706-9.

PMID:
16964715
29.

CRT-D therapy in heart failure: how much do NYHA class IV patients benefit?

Lehmann MH, Aaronson KD.

J Cardiovasc Electrophysiol. 2006 May;17(5):491-4. No abstract available.

30.

The long QT syndrome family of cardiac ion channelopathies: a HuGE review.

Modell SM, Lehmann MH.

Genet Med. 2006 Mar;8(3):143-55. Review.

PMID:
16540748
31.

Circumferential pulmonary-vein ablation for chronic atrial fibrillation.

Oral H, Pappone C, Chugh A, Good E, Bogun F, Pelosi F Jr, Bates ER, Lehmann MH, Vicedomini G, Augello G, Agricola E, Sala S, Santinelli V, Morady F.

N Engl J Med. 2006 Mar 2;354(9):934-41.

33.

Influence of gender on arrhythmia characteristics and outcome in the Multicenter UnSustained Tachycardia Trial.

Russo AM, Stamato NJ, Lehmann MH, Hafley GE, Lee KL, Pieper K, Buxton AE; MUSTT Investigators.

J Cardiovasc Electrophysiol. 2004 Sep;15(9):993-8.

34.

QT interval: metric for cardiac prognosis?

Lehmann MH, Morady F.

Am J Med. 2003 Dec 15;115(9):732-4. Review. No abstract available.

PMID:
14693327
35.

Modulating effects of age and gender on the clinical course of long QT syndrome by genotype.

Zareba W, Moss AJ, Locati EH, Lehmann MH, Peterson DR, Hall WJ, Schwartz PJ, Vincent GM, Priori SG, Benhorin J, Towbin JA, Robinson JL, Andrews ML, Napolitano C, Timothy K, Zhang L, Medina A; International Long QT Syndrome Registry.

J Am Coll Cardiol. 2003 Jul 2;42(1):103-9.

36.

Racial differences in outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT): a comparison of whites versus blacks.

Russo AM, Hafley GE, Lee KL, Stamato NJ, Lehmann MH, Page RL, Kus T, Buxton AE; Multicenter UnSustained Tachycardia Trial Investigators.

Circulation. 2003 Jul 8;108(1):67-72. Epub 2003 Jun 23.

PMID:
12821551
37.

Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the multicenter unsustained tachycardia trial.

Buxton AE, Lee KL, Hafley GE, Wyse DG, Fisher JD, Lehmann MH, Pires LA, Gold MR, Packer DL, Josephson ME, Prystowsky EN, Talajic MR; MUSTT Investigators.

Circulation. 2002 Nov 5;106(19):2466-72.

PMID:
12417544
38.

Pseudogene-free amplification of human GAPDH cDNA.

Lehmann MH, Weber J, Gastmann O, Sigusch HH.

Biotechniques. 2002 Oct;33(4):766, 769-70. No abstract available.

39.

Sex, shocks, and survival: sudden cardiac death prevention with implantable cardioverter defibrillators in women versus men.

Lehmann MH.

J Cardiovasc Electrophysiol. 2002 Jun;13(6):569-70. No abstract available.

PMID:
12108498
40.

Identification and validation of selective upregulation of ventricular myosin light chain type 2 mRNA in idiopathic dilated cardiomyopathy.

Haase D, Lehmann MH, Körner MM, Körfer R, Sigusch HH, Figulla HR.

Eur J Heart Fail. 2002 Jan;4(1):23-31.

41.

Differences in inducibility and prognosis of in-hospital versus out-of-hospital identified nonsustained ventricular tachycardia in patients with coronary artery disease: clinical and trial design implications.

Pires LA, Lehmann MH, Buxton AE, Hafley GE, Lee KL; Multicenter Unsustained Tachycardia Trial Investigators.

J Am Coll Cardiol. 2001 Oct;38(4):1156-62.

43.

Constitutive expression of MCP-1 and RANTES in the human histiocytic lymphoma cell line U-937.

Lehmann MH, Schreiber S, Vogelsang H, Sigusch HH.

Immunol Lett. 2001 Mar 1;76(2):111-3. No abstract available.

PMID:
11274728
44.

Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias.

Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, Denjoy I, Guicheney P, Breithardt G, Keating MT, Towbin JA, Beggs AH, Brink P, Wilde AA, Toivonen L, Zareba W, Robinson JL, Timothy KW, Corfield V, Wattanasirichaigoon D, Corbett C, Haverkamp W, Schulze-Bahr E, Lehmann MH, Schwartz K, Coumel P, Bloise R.

Circulation. 2001 Jan 2;103(1):89-95.

PMID:
11136691
45.

Angiotensin II type 1 receptor gene polymorphism is associated with the severity but not prevalence of coronary artery disease.

Surber R, Sigusch HH, Lehmann MH, Reinhardt D, Hoffmann A, Figulla HR.

Clin Genet. 2000 Sep;58(3):237-8. No abstract available.

PMID:
11076048
46.

Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2.

Splawski I, Shen J, Timothy KW, Lehmann MH, Priori S, Robinson JL, Moss AJ, Schwartz PJ, Towbin JA, Vincent GM, Keating MT.

Circulation. 2000 Sep 5;102(10):1178-85.

PMID:
10973849
47.

Tumour necrosis factor-alpha expression in idiopathic dilated cardiomyopathy: correlation to myocardial inflammatory activity.

Sigusch HH, Lehmann MH, Schnittler U, Reinhardt D, Figulla HR.

Cytokine. 2000 Aug;12(8):1261-6.

PMID:
10930309
48.

Lack of association between 27-bp repeat polymorphism in intron 4 of the endothelial nitric oxide synthase gene and the risk of coronary artery disease.

Sigusch HH, Surber R, Lehmann MH, Surber S, Weber J, Henke A, Reinhardt D, Hoffmann A, Figulla HR.

Scand J Clin Lab Invest. 2000 May;60(3):229-35.

PMID:
10885495
49.

Analysis of point mutation in exon 2 of CYP2E1 gene in renal cell/urothelial cancer patients in comparison with control population.

Farker K, Lehmann MH, Kästner R, Weber J, Janitzky V, Schubert J, Hoffmann A.

Int J Clin Pharmacol Ther. 2000 Jan;38(1):30-4.

PMID:
10667834
50.

Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes.

Zhang L, Timothy KW, Vincent GM, Lehmann MH, Fox J, Giuli LC, Shen J, Splawski I, Priori SG, Compton SJ, Yanowitz F, Benhorin J, Moss AJ, Schwartz PJ, Robinson JL, Wang Q, Zareba W, Keating MT, Towbin JA, Napolitano C, Medina A.

Circulation. 2000 Dec 5;102(23):2849-55.

PMID:
11104743

Supplemental Content

Loading ...
Support Center